Compounded tirzepatide — 7 proven safety facts.

Compounded tirzepatide is promoted online as a cheaper alternative to Mounjaro. Interest has surged since UK Mounjaro prices rose in September 2025.

This guide explains what compounded tirzepatide is, whether it is legal in the UK, the US crackdown, the UK factory raid, the real risks and the safe licensed alternatives you can use instead.

Compounded tirzepatide: what it is

Compounded tirzepatide is tirzepatide made outside the normal licensing system, usually by a pharmacy, clinic or unregulated manufacturer. It is not made by Eli Lilly and has not been approved as Mounjaro or Zepbound.

Compounding has a legitimate role when a patient has a special clinical need that no licensed product can meet. Mass-producing cheaper copies of a licensed weight loss medicine is a very different thing.

In the UK, the term is often used loosely for any unlicensed tirzepatide, including vials sold as “research” chemicals. None of these products has been checked by the MHRA.

7 proven safety facts at a glance

1. Compounded tirzepatide is not a licensed medicine in the UK
2. Mounjaro is the only licensed tirzepatide brand here
3. The US ended routine compounding after the shortage was declared over
4. In 2025, UK officers seized over 2,000 unlicensed tirzepatide and retatrutide pens in one raid
5. Research-use-only vials are not intended for humans
6. Dosing errors with vials have caused hospital admissions
7. A licensed prescriber can help you find an affordable, safe option

For the licensed dose steps, see our tirzepatide dosage chart.

Why people look for it

Cost is the biggest driver behind compounded tirzepatide. When UK list prices for Mounjaro rose sharply in September 2025, many people started searching for cheaper compounded tirzepatide.

Higher doses were hit hardest, with the list price of the 12.5mg and 15mg pens rising from £122 to £330 a month. Private prices for patients now range widely between providers.

Some people also see compounded tirzepatide promoted on social media as an easy way to save money. Our Mounjaro cost UK guide explains current licensed prices.

The US story

Most of the talk about compounded tirzepatide started in the United States. When Mounjaro and Zepbound were in short supply, US rules let pharmacies make copies.

Telehealth firms sold these copies widely at lower prices. The FDA then declared the tirzepatide shortage resolved in October 2024 and confirmed the decision in December 2024.

Date	US event
2022–2024	Tirzepatide shortage allows compounding
October 2024	FDA declares the shortage resolved
December 2024	FDA confirms its decision after review
February 2025	Deadline for smaller 503A pharmacies to stop routine compounding
March 2025	Deadline for larger 503B outsourcing facilities
2025	Court backs the FDA in a compounding industry challenge

Eli Lilly has also taken legal action against firms selling copies of its medicines. In the US, compounded tirzepatide is now largely limited to genuine individual clinical needs.

Is it legal in the UK?

In the UK, a medicine needs an MHRA licence before it can be sold. Mounjaro has this licence for type 2 diabetes and weight management.

Pharmacies can prepare unlicensed “specials”, but only when a prescriber decides an individual patient has a clinical need that a licensed product cannot meet. Saving money is not a valid reason.

Selling prescription-only medicines without a prescription is a criminal offence. Websites selling compounded tirzepatide or research vials to the public are operating outside the law.

The UK factory raid

In October 2025, MHRA officers and Northamptonshire Police raided an illegal weight loss jab factory in Northampton. It was the first illicit weight loss medicine factory found in the UK.

Officers seized more than 2,000 unlicensed tirzepatide and retatrutide pens ready for dispatch, tens of thousands of empty pens, raw ingredients and packaging equipment. The haul was valued at around £250,000.

The MHRA described it as the largest single seizure of trafficked weight loss medicines recorded worldwide. Products like these are untested and potentially deadly.

The real risks of unlicensed copies

• Wrong strength: a vial may contain more or less tirzepatide than the label claims
• Contamination: products made in unregulated conditions may not be sterile
• Fake ingredients: some products may contain something else entirely
• Dosing errors: drawing tiny doses from vials is easy to get wrong
• No supervision: side effects may go unnoticed
• No trial data: nobody knows how these exact products perform

Tirzepatide is a powerful medicine, and compounded tirzepatide removes the safeguards around it. Even the licensed version can cause significant side effects, so an incorrect dose from an unregulated vial can be dangerous.

Vials, powders and dosing errors

Licensed Mounjaro comes in a pre-filled KwikPen that delivers a set dose. Most compounded tirzepatide comes as powder or liquid in vials that must be mixed and measured with a syringe.

Converting between milligrams and syringe units confuses many people. A small mistake can mean taking several times the intended dose.

US regulators have received reports of people needing medical care after measuring compounded GLP-1 doses wrongly. Nausea, vomiting, dehydration and fainting are among the reported problems.

Research tirzepatide vials

Many UK websites sell tirzepatide as a research chemical, often shortened to “tirz”. These products are labelled “not for human use” to sidestep medicine laws.

Like compounded tirzepatide, these products are unlicensed and unchecked. Our research peptides UK legal guide explains the legal position, and our compounded semaglutide guide covers similar issues with semaglutide.

Compounded tirzepatide vs Mounjaro

Feature	Mounjaro (licensed)	Compounded or research tirzepatide
MHRA licence	Yes	No
Clinical trial evidence	Yes, large SURMOUNT trials	None for these products
Quality checks	Strict manufacturing standards	Unknown
Device	Pre-filled KwikPen	Vials and syringes, or unbranded pens
Prescriber support	Yes	Usually none
Legal to sell to the public	Only with a prescription	No

In SURMOUNT-1, licensed tirzepatide led to average weight loss of 15.0%, 19.5% and 20.9% at the 5mg, 10mg and 15mg doses. Those results cannot be assumed for compounded tirzepatide.

How to spot unlicensed tirzepatide

• It is sold as a vial, powder or unbranded pen
• No medical consultation is needed
• The seller is not registered with the General Pharmaceutical Council
• It is labelled “research use only”
• The price is far below any licensed UK provider
• It is promoted through social media messages or groups

Genuine UK Mounjaro comes as a branded KwikPen in sealed packaging with a UK patient leaflet. It is always prescribed after a consultation.

Cutting the cost safely

If price is pushing you towards compounded tirzepatide, there are safer ways to reduce costs.

• Compare GPhC-registered providers, as prices vary widely
• Ask your prescriber whether a lower maintenance dose suits you
• Look for providers offering payment plans
• Check NHS eligibility through your GP
• Consider Wegovy if it suits your needs and budget

Read our cheapest way to buy Mounjaro UK and Mounjaro payment plans UK guides, or compare options in Wegovy vs Mounjaro.

If you have already used it

If you have used compounded tirzepatide, speak to a doctor or pharmacist. Be open about what you took, so they can give you the right advice.

If you switch to licensed Mounjaro, your prescriber will usually restart at a low dose. Our tirzepatide dosage chart shows each step.

Report side effects or suspected fake products through the MHRA Yellow Card scheme. Keep any packaging, as it can help investigators.

Most people find the move to a licensed KwikPen reassuring. You know exactly what dose you are taking, and a prescriber is there if anything goes wrong.

Side effects to watch for

Licensed tirzepatide commonly causes nausea, diarrhoea, constipation and reduced appetite, especially after dose increases. With compounded tirzepatide, these can be stronger if the dose is wrong.

• Severe stomach pain that spreads to your back
• Repeated vomiting or being unable to keep fluids down
• Signs of dehydration, such as dizziness and dark urine
• Redness, swelling or heat at an injection site

Get urgent medical help for any of these. Our Mounjaro side effects guide explains what is normal on licensed treatment.

Who is being targeted

Sellers of compounded tirzepatide often target people who have been priced out of licensed treatment. Messages on social media promise the same results for a fraction of the cost.

Some sellers pose as clinics or pharmacies, with professional-looking websites and fake reviews. Others sell through private messaging groups, which makes them hard to trace.

People who have already had good results on Mounjaro are a common target, because they want to keep going but struggle with the new price. That makes it especially important to know the risks of compounded tirzepatide before switching.

Europe and Ireland

Across Europe, tirzepatide is also only legal as a licensed medicine. National regulators have warned about fake weight loss pens and illegal online sellers.

Prices for licensed Mounjaro vary widely between countries, which drives some people to look abroad. Our tirzepatide price Europe guide compares licensed prices across the region.

Buying compounded tirzepatide from overseas websites carries the same risks as buying in the UK, plus the chance of parcels being seized at the border.

Questions to ask any provider

• Is the medicine licensed by the MHRA?
• Is it branded Mounjaro in a KwikPen?
• Are you registered with the General Pharmaceutical Council?
• Will a prescriber review my medical history?
• Who can I contact if I have side effects?

A legitimate provider will answer all of these clearly. If they hesitate, or offer compounded tirzepatide without a consultation, walk away.

Thinking of stopping?

Some people turn to compounded tirzepatide because they cannot afford to continue Mounjaro but fear regaining weight if they stop. That fear is understandable.

In the SURMOUNT-4 trial, people who stopped tirzepatide regained a significant amount of weight, around 14% on average. Planning a safe exit or lower maintenance dose with a prescriber is far better than switching to an unlicensed product.

Our Mounjaro stops working guide also explains what to do if your weight loss slows.

How the trend reached the UK

Compounded tirzepatide first became widespread in the US during the shortage years. Social media, online clinics and influencer marketing spread the idea across the Atlantic.

In the UK, the rise of private online pharmacies made licensed Mounjaro easy to access, and many people started treatment. When prices rose in 2025, unlicensed sellers stepped in to target those patients.

Regulators have responded with warnings, website takedowns and raids. Even so, compounded tirzepatide and research vials remain easy to find online.

How UK regulators respond

• Seizing unlicensed weight loss pens and vials
• Shutting down illegal websites and social media accounts
• Investigating sellers supplying prescription medicines without a prescription
• Collecting reports through the Yellow Card scheme

The General Pharmaceutical Council also regulates online pharmacies. Any pharmacy supplying compounded tirzepatide to the public as a cheaper Mounjaro risks action.

If you see compounded tirzepatide advertised, you can report the seller to the MHRA. Reports help protect other people from unsafe products.

Licensed options compared

Option	Form	Licensed for	Notes
Mounjaro	Weekly KwikPen	Weight management and type 2 diabetes	Doses from 2.5mg to 15mg
Wegovy	Weekly pen	Weight management	Semaglutide, up to 2.4mg or 7.2mg
Wegovy pill	Daily tablet	Weight management	Needle-free semaglutide option

Each has full trial data and an MHRA licence, unlike compounded tirzepatide. Compare them in our semaglutide vs tirzepatide guide.

Is a generic coming?

Unlike semaglutide, tirzepatide is a newer medicine with patent protection that runs well into the 2030s. No licensed generic is expected in the UK or Europe for years.

That means compounded tirzepatide is not an early generic. It is simply unlicensed. Read our generic semaglutide guide to see how generics work.

Unlicensed vials and microdosing

Some people use compounded tirzepatide to microdose, taking tiny amounts from vials. This combines two risks: an unlicensed product and an untested dosing method.

There is no trial evidence for very low doses. Our semaglutide microdosing guide explains why experts warn against the trend.

Storage and temperature

Licensed Mounjaro pens are kept chilled through a controlled supply chain, unlike most compounded tirzepatide. Compounded tirzepatide may be posted without proper cooling, which can damage the medicine.

Once mixed, vials may also be stored incorrectly or used for too long. Our how to store GLP-1 peptides guide explains why temperature matters.

Getting started safely

Starting licensed tirzepatide safely is straightforward. A registered provider will ask about your health, weight history and medicines before prescribing.

• Complete an online or in-person consultation
• Share your medical history honestly
• Start at the 2.5mg dose and increase gradually
• Report side effects to your prescriber
• Attend regular reviews to track progress

Our how to inject Mounjaro guide walks you through using the KwikPen, and our Mounjaro weight loss results guide shows what to expect.

This path costs more than an unregulated vial, but every step is designed to keep you safe. Your prescriber can also adjust the plan if side effects or cost become a problem.

Key takeaways

• Compounded tirzepatide is not licensed in the UK
• The US ended routine compounding in 2025
• A UK raid seized over 2,000 unlicensed tirzepatide and retatrutide pens
• Vials and research products carry serious dosing and quality risks
• Licensed Mounjaro with a prescriber is the safe route

Ready to start with genuine tirzepatide? Our Mounjaro product page shows pricing at every dose, and our tirzepatide UK guide explains how it works.